Evidence map›Paper›PMID 26156446›Full record

ArticleInternal and emergency medicine2015

Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department.

Ivo Casagranda, Chiara Vendramin, Tiziana Callegari, Matteo Vidali, Alessandra Calabresi, Giovanna Ferrandu, Gianfranco Cervellin, Mario Cavazza, Giuseppe Lippi, Isabella Zanotti and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Free Radical-Associated Gene Signature Predicts Survival in Sepsis Patients.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Cytokine Storm-Definition, Causes, and Implications.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Observational
  14. An Update on Sepsis Biomarkers.Infection & chemotherapy · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ivo CasagrandaEmergency Department, SS. Antonio e Biagio e Cesare Arrigo Hospital, Via Venezia 16, 15100, Alessandria, Italy, icasagranda@ospedale.al.it.
Chiara Vendramin
Tiziana Callegari
Matteo Vidali
Alessandra Calabresi
Giovanna Ferrandu
Gianfranco Cervellin
Mario Cavazza
Giuseppe Lippi
Isabella Zanotti
Sophie Negro
Andrea Rocchetti
Carlo Arfini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the role of suPAR in patients with sepsis admitted to the Emergency Department (ED). We performed multicentre prospective trial including patients admitted to the ED of three different Italian hospitals. Patients were studied upon admission on day 1, 2, 4 and 7. They were subdivided into two groups: sepsis (group 1) and severe sepsis or septic shock (group 2). The two groups were comparable for age, gender and CRP level on day 1. Patients with severe sepsis or septic shock displayed significantly higher baseline levels of suPAR, PCT and lactate. In both groups, suPAR decreased across the time (p < 0.0005). Group 1 was not different from group 2 (p = 0.545) in mortality at 7 days, while group 2 had higher mortality at 30 days than group 1 (p = 0.022). At the multivariate analysis, lactate1 (p = 0.012) and age (p = 0.019) were independent predictors of mortality at 7 days, whereas suPAR1 (p = 0.023) and age (p = 0.032) were independent predictors of mortality at 30 days. Lactate and suPAR resulted the most predictive biomarkers in the risk stratification of patients with suspected infection initially admitted to the ED, according to their role in predicting 7- and 30-day mortality, respectively.

Indexed as

AgedAged, 80 and overBiomarkersEmergency Service, HospitalFemaleHumansMalePeptide FragmentsPrognosisProspective StudiesProtein PrecursorsRisk AssessmentSepsisUrokinase-Type Plasminogen Activatoracetyl-lysyl-prolyl-seryl-seryl-prolyl-prolyl-glutamyl-glutamic acid amideBiomarkersPeptide FragmentsProtein PrecursorsUrokinase-Type Plasminogen Activator

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.